About this trial

The investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.

Eligibility criteria

Qualifiers

Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for acne scarring

Subject must voluntarily sign and date an IRB approved informed consent form

Subjects with diagnosis of acne scarring recorded over the past 6 months

Able to read, understand and voluntarily provide written informed consent.

Disqualifiers

Subjects does not have the capacity to consent to the study

subject underwent any acne scar treatments in the past 6 months prior to enrollment in the study

Subject has active papulopustular or cystic acne within the past 6 months.

Any history of keloidal scarring.

Trial design

Treatments tested in this trial

  • Sciton Halo

Treatment groups

46 Participants
are divided into 2 treatment groups

Locations

1
555 Taxter Road10523, ElmsfordNew York, United States

Sponsors and collaborators

Albert Einstein College of Medicine

Lead sponsor